The rising interest in GLP-1 agonists for metabolic conditions has sparked a question about formats: transdermal systems versus tablets . Typically, GLP-1 treatments were solely available in tablet https://jakubmijs199414.isblog.net/glp-1-skin-applications-vs-pills-is-suitable-for-the-patient-58253911